Physiological, Cognitive, and Personal Features in the Link Between Placebo-effect and Variability of Pain Reports
Primary Purpose
Chronic Back Pain
Status
Recruiting
Phase
Not Applicable
Locations
Israel
Study Type
Interventional
Intervention
NaCl 0.9% (normal saline)
Magnetized Normal Saline
Sponsored by
About this trial
This is an interventional basic science trial for Chronic Back Pain
Eligibility Criteria
Inclusion Criteria: Literate adults Aged 18 - 80 years A diagnosis of chronic back pain Sufferings from back pain during the last 3 months or more, with an intensity of 3 or more on a 0-10 NRS Exclusion Criteria: Mental retardation or cognitive impairment Pregnancy or breast-feeding Malignancy and a diagnosis of malignant disease
Sites / Locations
- Galilee Medical centerRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Placebo Comparator
Active Comparator
Arm Label
Normal Saline
Magnetized Normal Saline
Arm Description
0.5 milliliter of NACL 0.9% subcutaneous saline injection
0.5 milliliter of magnetized NACL 0.9% subcutaneous saline injection
Outcomes
Primary Outcome Measures
Reduction of pain following placebo injection
The reduction in pain intensity on the 0-100 numerical rating scale (NRS) after normal saline injection
Within-subjects variability of day-to-day clinical pain reports
The variance of within person pain scores reported on a 0-100 Visual Analog Scale VAS during 7 days via pain-dairy at baseline
Secondary Outcome Measures
The Focused Analgesia selection task (FAST)
Experimental paradigm which allow calculation of within-subjects variability of pain reports in response to thermal stimuli
Full Information
NCT ID
NCT05994118
First Posted
April 13, 2022
Last Updated
August 15, 2023
Sponsor
University of Haifa
Collaborators
Western Galilee Hospital-Nahariya
1. Study Identification
Unique Protocol Identification Number
NCT05994118
Brief Title
Physiological, Cognitive, and Personal Features in the Link Between Placebo-effect and Variability of Pain Reports
Official Title
Exploring the Role of Physiological, Cognitive, and Personal Features in the Link Between Placebo-effect and Variability of Pain Reports
Study Type
Interventional
2. Study Status
Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 21, 2021 (Actual)
Primary Completion Date
September 2023 (Anticipated)
Study Completion Date
March 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Haifa
Collaborators
Western Galilee Hospital-Nahariya
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study attempt to identify whether and how factors known or considered to be related with analgesic placebo effect or variability of pain reports separately, may contribute to their coupling. Among these factors - personal traits such as optimism, focus of attention, suggestibility, and short-term memory along with characteristics of stress and relaxation. Additionally, the role of pain sensitivity and the individual's pain modulation profile in the relationship between analgesic placebo effect and variability of pain reports will be examined.
Detailed Description
Data will be collected from 130 patients with non-specific chronic back pain that will be recruited for a prospective cross-sectional study. To characterize the main study variables, the participants will undergo the Focused analgesia selection test (FAST) which evaluates within-subjects variability of pain reports, and placebo manipulation containing administration of an inert injection accompanied by a verbal suggestion, which is expected to produce placebo effects. The involvement of additional factors considered associated with the within-subjects variability of pain reports and the placebo response will be explored. Stress and well-being characteristics will be examined by measuring cortisol levels in saliva and in hair, salivary level of Secretory Immune globulin A (SIgA), and an autonomic nervous system function and a stress perception questionnaire. Personal traits such as suggestibility, optimism, and Focus of attention, will be examined using questionnaires. Memory will be assessed by memory task, and factors related to the pain modulation system will be examined using psychophysical tests, and a pain sensitivity questionnaire.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Back Pain
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Subcutaneous injection of Saline solution (NACL 0.9%) in the buttock
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
150 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Normal Saline
Arm Type
Placebo Comparator
Arm Description
0.5 milliliter of NACL 0.9% subcutaneous saline injection
Arm Title
Magnetized Normal Saline
Arm Type
Active Comparator
Arm Description
0.5 milliliter of magnetized NACL 0.9% subcutaneous saline injection
Intervention Type
Other
Intervention Name(s)
NaCl 0.9% (normal saline)
Intervention Description
Subcutaneous normal saline injection
Intervention Type
Other
Intervention Name(s)
Magnetized Normal Saline
Intervention Description
Magnetized Normal Saline
Primary Outcome Measure Information:
Title
Reduction of pain following placebo injection
Description
The reduction in pain intensity on the 0-100 numerical rating scale (NRS) after normal saline injection
Time Frame
Half an hour after injection
Title
Within-subjects variability of day-to-day clinical pain reports
Description
The variance of within person pain scores reported on a 0-100 Visual Analog Scale VAS during 7 days via pain-dairy at baseline
Time Frame
7 days before study visit
Secondary Outcome Measure Information:
Title
The Focused Analgesia selection task (FAST)
Description
Experimental paradigm which allow calculation of within-subjects variability of pain reports in response to thermal stimuli
Time Frame
Once, at baseline
Other Pre-specified Outcome Measures:
Title
Pain modulation - Temporal Summation
Description
Change in pain intensity on the 0-100 numerical rating scale (NRS) in response to the first and last electrical noxious stimuli
Time Frame
Once, at baseline
Title
Pain modulation - Conditioned pain modulation
Description
Change in pain intensity on the 0-100 numerical rating scale (NRS) in response to concurrent noxious stimuli
Time Frame
Once, at baseline
Title
Biological markers - cortisol
Description
Saliva cortisol levels
Time Frame
1 day (Before and after administration of saline)
Title
Biological markers - secretory IgA
Description
Saliva secretory IgA level
Time Frame
1 day (Before and after administration of saline)
Title
Biological markers - oxytocin
Description
Saliva oxytocin level
Time Frame
1 day (Before and after administration of saline)
Title
Autonomic measures - Heart rate variability
Description
As measured by a monitor
Time Frame
1 day (Before and after administration of saline)
Title
Autonomic measures - blood pressure
Description
As measured by a monitor
Time Frame
1 day (Before and after administration of saline)
Title
Short-term memory
Description
via the Digit Span test
Time Frame
Once, at baseline
Title
Pain sensitivity via QST
Description
Mechanical pain thresholds
Time Frame
1 day (Before and after administration of saline)
Title
Questionnaire - Optimism
Description
Via the life orientation test revised (LOT-R)
Time Frame
Once, at baseline
Title
Questionnaire - pain sensitivity
Description
Via the pain sensitivity questionnaire (PSQ)
Time Frame
Once, at baseline
Title
Questionnaire - interoceptive awareness
Description
Via the Multidimensional assessment of interoceptive awareness (MAIA questionnaire)
Time Frame
Once, at baseline
Title
Questionnaire - direction of attention
Description
Via the Self consciousness scale revised
Time Frame
Once, at baseline
Title
Questionnaire Body awareness
Description
via the body awareness Questionnaire (BAQ)
Time Frame
Once, at baseline
Title
Questionnaire - suggestibility
Description
Via the short suggestibility scale (SSS)
Time Frame
Once, at baseline
Title
Questionnaire - expectations
Description
via the expect Questionnaire
Time Frame
Once, at baseline
Title
Questionnaire - perceived stress
Description
via the perceived stress scale
Time Frame
Once, at baseline
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Literate adults
Aged 18 - 80 years
A diagnosis of chronic back pain
Sufferings from back pain during the last 3 months or more, with an intensity of 3 or more on a 0-10 NRS
Exclusion Criteria:
Mental retardation or cognitive impairment
Pregnancy or breast-feeding
Malignancy and a diagnosis of malignant disease
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Roi Treister, PhD
Phone
0533839935
Email
rtreister@univ.haifa.ac.il
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Roi Treister, PhD
Organizational Affiliation
University of Haifa
Official's Role
Principal Investigator
Facility Information:
Facility Name
Galilee Medical center
City
Nahariyya
ZIP/Postal Code
2210001
Country
Israel
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Adi Shani, MA
Phone
+972-524239112
Email
a.eilat888@gmail.com
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Once published, the data (without any personal identification) will be available upon request
Learn more about this trial
Physiological, Cognitive, and Personal Features in the Link Between Placebo-effect and Variability of Pain Reports
We'll reach out to this number within 24 hrs